Pharmaceutical Supply – Dextrose Injection (NSN 6505015015408)

The contract entails the manufacture and supply of sterile Dextrose Injection meeting all federal and medical standards for safety, purity, and efficacy, with mandatory proper labeling and assigned National Drug Code (NDC) numbers to ensure regulatory compliance. The product is intended for delivery to a government destination under the oversight of the Defense Logistics Agency, part of the Department of Defense, and is identified by the National Stock Number 6505015015408. The agreement falls under the NAICS code 325412, specifying pharmaceutical preparation manufacturing, and is structured as a subcontract within the broader defense medical supply chain. Delivery requirements align with strict military and federal healthcare protocols, ensuring that every unit is traceable, properly packaged, and conforms to applicable quality control guidelines. The contract was posted on August 9, 2026, and is associated with the primary contract SPE2DX25D8022 and delivery order SPE2D926F8061, indicating its role in a larger procurement effort. While the exact place of performance and point of contact details are unspecified, the operational focus remains on fulfilling the DLA's supply chain needs with reliable, sterile pharmaceuticals sourced in accordance with defense and medical regulations.